The Rundown: ExL’s Blog

Viewing 71 to 80 of 103 records.

Twelve years after T.J. Sharpe’s successful melanoma surgery, the husband and father-of-two saw the return of his skin cancer. Faced once again with the unexpected realization of mortality after more than a decade of remission, a clinical trial helped ensure Sharpe would see his children grow up. This patient and survivor is helping spread the word about clinical trials, and how they should be an available option for others like him.

The return of Sharpe’s melanoma was accompanied by a predicted life expectancy of less than two years. He was adamant on…

As we come approach the midway mark of 2017, we can’t help but wonder how the passage of time is affecting the pharmaceutical industry. Regarding U.S. patents on certain drugs, some big-name pharma companies are looking at big-time losses in 2017. Companies like Takeda, Pfizer, Gilead, Eli Lilly, and Bristol-Myers Squibb are doing their best to hold onto these coveted drug patents, but odds are that they won’t have such great luck. According to a recently published content report from FiercePharma, a handful of popular drug patents in the U.S. are expiring.

Since drug pricing was a noted talking point of the 2016 presidential election, it might not come as a surprise that R&D budgets in the pharmaceutical industry have seen big cuts as a result. And while this comes across as a negative, reduced spending on pharma R&D – though resulting in staff cuts, restructured operations, and more – actually resulted in positive percentage terms in sales. Luckily for us, FierceBiotech has made this information easy to understand in a recently published content report.

ExL Events is excited to announce that we’ve been selected as the exclusive conference partner on a series of promotional, event service, and content exchange with the Medical Affairs Professional Society (MAPS)! While MAPS is a relatively new association, it has proved itself as one of the most formidable organizations in the medical affairs segment. MAPS has been impressing the ExL team since we started covering it in the early 2000s. Find out more about our new partner below!

ExL Events’ co-founder and COO, Ethan Denkensohn, had this to say about the exciting…

ExL Events would like to congratulate our speaker alumnus Dr. Scott Gottlieb for the recent United States Senate confirmation, naming him the new Food and Drug Administration commissioner. Dr. Gottlieb was the keynote speaker at ExL’s 2nd Trial Design Innovation Conference and was also a featured speaker at our Private Fee-for-Service event.

President Donald Trump nominated Gottlieb earlier this year, for his previous service as deputy commissioner for the FDA, as well as his experience in the pharmaceutical and health care industries. As the FDA’s newly appointed commissioner, Gottlieb will…

This guest blog post is written by Dan Cohen, the Forum Chair of the Abuse Deterrent Coalition and speaker at the 3rd Human Abuse Liability & Abuse-Deterrent Formulations conference, which takes place in Arlington, VA this November 2-3.

The prominence of Abuse Deterrent Formulations (ADF) in the public policy debate has never been greater. This fall is no exception as we are now at yet another critical juncture for the ADF sector, with…

Acquisition of Leading Life Sciences Event Company Expands Company’s Services in Pharmaceutical, Life Science and Healthcare Markets
Questex, a leading global business information and events company, today announced it has acquired ExL Events, Inc., expanding Questex’s presence in the global pharmaceutical, life science and healthcare markets.

ExL Events, founded in 2004 as ExL Pharma, is the industry leader in developing innovative, educational conferences that serve the pharmaceutical, life science and healthcare communities. Kerry Gumas, Questex President and Chief Executive Officer,…

Content marketing is one of the most effective tools life science professionals have in their arsenal. Developing an effective campaign, however, can be difficult. We’ve put together these simple tips to help guide you in the right direction.
Tip #1: Know Your Audience.
Before you start creating content, be sure you know the answer to this simple question: Who are you trying to reach? Keeping your target audience in mind as you create content can be the difference between a successful campaign and one that falls short. For instance,…

To learn more about Dave, visit www.djhmarcom.com, email him at djhochman@djhmarcom.com or follow him on Twitter @davehochman.
Q: What can other industries look to pharma for right now in terms of ideas and inspiration beyond endorsements and collaborations…

This guest blog post is written by Dave Hochman, and is part one of an interview Dave performed following the 11th Public Relations & Communications Summit in July 2015.

Dave is the owner of the Red Bank, NJ-based DJH Marketing Communications, Inc. To learn more about Dave, visit www.djhmarcom.com, email him at djhochman@djhmarcom.com or follow him on Twitter @davehochman.

After the 11th Public Relations & Communications Summit took place in July, we were fortunate enough to be able to circle back with some of the…

Featured Partners

Kelly Willenberg LLC is a full service research compliance organization serving clients on improving operations. She employs technologies to improve operational aspects of compliance based on client needs. She assists in the implementation of billing compliance programs, offers training seminars, builds coverage analysis and helps with process improvement. She can also assist with process improvement, quality assurance and assessing vulnerabilities in all aspects of research compliance.Read more.

FiercePharma is a digital media publication, reporting and delivering daily news and objective analysis for business professionals in global industries. FiercePharma offers broad coverage serving a wide range of specific functional interests, including manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline; and the influence of big data, executive moves and social media on it all.

Latest Blog Post

Message From the Pharmacovigilance Audit and Inspections Conference Chair

It is a distinguished privilege to chair ExL Events’ Pharmacovigilance Audit and Inspections Conference on March 26–27 in Philadelphia. As the conference chairperson, I am eager to welcome you to this benchmark event.

Connect With Us

In addition to conferences, ExL Events also provides industry-related content through a variety of social platforms. Be sure to follow the profiles that fit your topics of interest to gain access to the latest content and industry news.